Table 2.
Initial RNA Level | |||||
---|---|---|---|---|---|
Sample | 5 ng | 10 ng | 20 ng | 40 ng | Histologic Type |
FNA‐1 | Failed assay QC | Failed assay QC | Benign | Benign | Nodular hyperplasia |
FNA‐2 | Benign | Malignant | Malignant | Malignant | Papillary carcinoma |
FNA‐3 | Malignant | Malignant | Malignant | Malignant | Papillary carcinoma |
FNA‐4 | Benign | Benign | Benign | Benign | Papillary carcinoma |
FNA‐5 | Malignant | Malignant | Malignant | Malignant | Papillary carcinoma |
FNA‐6 | Benign | Benign | Benign | Benign | Follicular adenoma |
FNA‐7 | Failed assay QC | Malignant | Malignant | Benign | Follicular adenoma |
FNA‐8 | Failed assay QC | Benign | Benign | Benign | Nodular hyperplasia |
FNA‐9 | Malignant, medullary | Malignant, medullary | Malignant, medullary | Malignant, medullary | Medullary carcinoma |
FNA‐10 | Benign | Benign | Benign | Benign | Nodular hyperplasia |
FNA‐11 | Malignant | Malignant | Malignant | Malignant | Papillary carcinoma |
FNA‐12 | Benign | Benign | Benign | Failed assay QC | Nodular hyperplasia (nodular goiter) |
Abbreviations: FNA, fine‐needle aspiration; QC, quality control.